Biostar Stem Cell Research Institute , which is co-operated by NATURE CELL and R-bio, published that a third clinical center for the phases 1 and 2 of ‘AstroStem’, a stem cell drug for Alzheimer’s disease that is currently undergoing clinical trials following the approval from the U.S. FDA, has been additionally selected.